Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Stefano De Santis, Maria Domenica Simone, Sebastiano Mercadante, Rocco Domenico Mediati, Renato Vellucci, Paolo Marchetti, Giuseppe Tonini, Arturo Cuomo, Augusto Caraceni, Silvia Natoli, Grazia Armento, Livio Blasi & Massimo Mammucari. (2021) Oxycodone/Acetaminophen: The Tailoring Combination Treatment for Specific Clinical Profile of Opioid Well-Responsive Cancer Pain. Cancer Management and Research 13, pages 1747-1756.
Read now
Read now
Carlos Camps Herrero, Antonio Antón Torres, Juan Jesús Cruz-Hernández, Alfredo Carrato, Manuel Constenla, Eduardo Díaz-Rubio, Margarita Feyjoo Saus, Jesus Garcia-Foncillas, Pere Gascón & Vicente Guillem. (2019) Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts. Journal of Pain Research 12, pages 2349-2358.
Read now
Read now
Sebastiano Mercadante. (2017) Fentanyl products in the management of episodic pain in the cancer patient. Expert Review of Quality of Life in Cancer Care 2:1, pages 41-45.
Read now
Read now
Sebastiano Mercadante, Flavio Fusco, Amanda Caruselli, Claudio Cartoni, Francesco Masedu, Marco Valenti & Federica Aielli. (2017) Background and episodic breathlessness in advanced cancer patients followed at home. Current Medical Research and Opinion 33:1, pages 155-160.
Read now
Read now
Sebastiano Mercadante, Giovanna Prestia & Alessandra Casuccio. (2013) The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen. Current Medical Research and Opinion 29:11, pages 1527-1532.
Read now
Read now
Sebastiano Mercadante, Alessandro Valle, Giampiero Porzio, Federica Aielli, Claudio Adile, Corrado Ficorella, Maurizio Raineri, Antonino Giarratano & Alessandra Casuccio. (2013) Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. Current Medical Research and Opinion 29:6, pages 667-671.
Read now
Read now
Articles from other publishers (26)
Sebastiano Mercadante. (2023) Once again... breakthrough cancer pain: an updated overview. Journal of Anesthesia, Analgesia and Critical Care 3:1.
Crossref
Crossref
Luis Cabezón-GutiérrezCecilio Álamo-GonzálezDiana Monge-MartínFernando Caballero-Martínez. (2022) Analyzing Differences in Perception between Oncologists and Patients to Adapt Pharmacological Treatment for Breakthrough Cancer Pain: Observational ADAPTATE Study. Journal of Palliative Medicine 25:6, pages 925-931.
Crossref
Crossref
Sebastiano Mercadante & Russell K. Portenoy. (2021) Understanding the Chameleonic Breakthrough Cancer Pain. Drugs 81:4, pages 411-418.
Crossref
Crossref
C. Camps Herrero, N. Batista, N. Díaz Fernández, Y. Escobar Álvarez, A. Gonzalo Gómez, D. Isla Casado, A. Salud, J. Terrasa Pons & V. Guillem Porta. (2020) Breakthrough cancer pain: review and calls to action to improve its management. Clinical and Translational Oncology 22:8, pages 1216-1226.
Crossref
Crossref
F. V. Estévez, Mª D. L. Alarcón, V. Mayoral, M. de Madariaga, C. Margarit, J. A. Duran, J. M. T. Martín-Arroyo & A. Carregal. (2019) Current management of breakthrough cancer pain according to physicians from pain units in Spain. Clinical and Translational Oncology 21:9, pages 1168-1176.
Crossref
Crossref
Ersilia Lucenteforte, Laura Vagnoli, Alessandra Pugi, Giada Crescioli, Niccolò Lombardi, Roberto Bonaiuti, Maurizio Aricò, Sabrina Giglio, Andrea Messeri, Alessandro Mugelli, Alfredo Vannacci & Valentina Maggini. (2018) A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study. BMC Cancer 18:1.
Crossref
Crossref
Erik Torbjørn Løhre, Marianne Jensen Hjermstad, Cinzia Brunelli, Anne Kari Knudsen, Stein Kaasa & Pål Klepstad. (2018) Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study. Pain and Therapy 7:2, pages 193-203.
Crossref
Crossref
Keita TagamiAyumi OkizakiTomofumi MiuraYuki Sumazaki WatanabeYoshihisa MatsumotoTatsuya MoritaMaiko FujimoriHiroya Kinoshita. (2018) Breakthrough Cancer Pain Influences General Activities and Pain Management: A Comparison of Patients with and without Breakthrough Cancer Pain. Journal of Palliative Medicine 21:11, pages 1636-1640.
Crossref
Crossref
Mette Frahm Olsen, Eik Bjerre, Maria Damkjær Hansen, Britta Tendal, Jørgen Hilden & Asbjørn Hróbjartsson. (2018) Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies. Journal of Clinical Epidemiology 101, pages 87-106.e2.
Crossref
Crossref
Sebastiano Mercadante, Paolo Marchetti, Arturo Cuomo, Augusto Caraceni, Rocco Mediati, Renato Vellucci, Massimo Mammucari, Silvia Natoli, Marzia Lazzari, Mario Dauri, Claudio Adile, Mario Airoldi, Giuseppe Azzarello, Mauro Bandera, Livio Blasi, Giacomo Cartenì, Bruno Chiurazzi, Benedetta Costanzo, Daniela Degiovanni, Flavio Fusco, Vittorio Guardamagna, Vincenzo Iaffaioli, Simeone Liguori, Loredana Palermo, Sergio Mameli, Francesco Masedu, Rodolfo Mattioli, Teresita Mazzei, Rita Melotti, Valentino Menardo, Danilo Miotti, Stefano Moroso, Gaetano Pascoletti, Stefano De Santis, Remo Orsetti, Alfonso Papa, Sergio Ricci, Elvira Scelzi, Michele Sofia, Giuseppe Tonini, Alessandro Valle & Federica Aielli. (2018) Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients. Cancers 10:6, pages 175.
Crossref
Crossref
Mellar Davis & Nathan Pennell. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology
608
619.e8
.
Mette Frahm Olsen, Eik Bjerre, Maria Damkjær Hansen, Jørgen Hilden, Nino Emanuel Landler, Britta Tendal & Asbjørn Hróbjartsson. (2017) Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain. BMC Medicine 15:1.
Crossref
Crossref
Yolanda Escobar Alvarez, Claudia Agamez Insignares, Monica Ahumada Olea, Olga Barajas, German Calderillo, Jenny Cecilia Calvache Guamán, Ricardo Caponero, Benjamín A Cavenago Salazar, Auro Del Giglio, Ana Rocío Pupo Araya, Ricardo Villalobos-Valencia, Andrés Yepes Pérez & Nilda Zumelzu Delgado. (2017) Cancer pain management: recommendations from a Latin-American experts panel. Future Oncology 13:27, pages 2455-2472.
Crossref
Crossref
Sebastiano Mercadante, Claudio Adile, Arturo Cuomo, Federica Aielli, Franco Marinangeli & Alessandra Casuccio. (2016) The use of low doses of a sublingual fentanyl formulation for breakthrough pain in patients receiving low doses of opioids. Supportive Care in Cancer 25:2, pages 645-649.
Crossref
Crossref
Sebastiano Mercadante, Paolo Marchetti, Arturo Cuomo, Augusto Caraceni, Rocco Domenico Mediati, Massimo Mammucari, Silvia Natoli, Marzia Lazzari, Mario Dauri, Mario Airoldi, Giuseppe Azzarello, Mauro Bandera, Livio Blasi, Giacomo Cartenì, Bruno Chiurazzi, Benedetta Veruska Pierpaola Costanzo, Daniela Degiovanni, Flavio Fusco, Vittorio Guardamagna, Vincenzo Iaffaioli, Simeone Liguori, Vito Lorusso, Sergio Mameli, Rodolfo Mattioli, Teresita Mazzei, Rita Maria Melotti, Valentino Menardo, Danilo Miotti, Stefano Moroso, Stefano De Santis, Remo Orsetti, Alfonso Papa, Sergio Ricci, Alessandro Fabrizio Sabato, Elvira Scelzi, Michele Sofia, Giuseppe Tonini, Federica Aielli & Alessandro Valle. (2016) Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS). Advances in Therapy 34:1, pages 120-135.
Crossref
Crossref
Sebastiano Mercadante & Russell K. Portenoy. (2016) Breakthrough cancer pain: twenty-five years of study. Pain 157:12, pages 2657-2663.
Crossref
Crossref
Sebastiano Mercadante & Arturo Cuomo. (2016) Breakthrough Cancer Pain: Ten Commandments. Value in Health 19:5, pages 531-536.
Crossref
Crossref
Sebastiano Mercadante, Federica Aielli, Claudio Adile, Andrea Costanzi & Alessandra Casuccio. (2016) Fentanyl Pectin Nasal Spray Versus Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Comparative Study. Journal of Pain and Symptom Management 52:1, pages 27-34.
Crossref
Crossref
Erik Torbjørn Løhre, Pål Klepstad, Michael I. Bennett, Cinzia Brunelli, Augusto Caraceni, Robin L. Fainsinger, Anne Kari Knudsen, Sebastiano Mercadante, Per Sjøgren & Stein Kaasa. (2016) From “Breakthrough” to “Episodic” Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations. Journal of Pain and Symptom Management 51:6, pages 1013-1019.
Crossref
Crossref
Sebastiano Mercadante, Paolo Marchetti, Arturo Cuomo, Massimo Mammucari & Augusto Caraceni. (2015) Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Supportive Care in Cancer 24:2, pages 961-968.
Crossref
Crossref
Sebastiano Mercadante, Federica Aielli, Claudio Adile, Alessandro Valle, Flavio Fusco, Patrizia Ferrera, Amanda Caruselli, Claudio Cartoni, Paolo Marchetti, Giuseppe Bellavia, Andrea Cortegiani, Francesco Masedu, Marco Valenti & Giampiero Porzio. (2016) Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational Study. Journal of Pain and Symptom Management 51:1, pages 17-24.
Crossref
Crossref
Sebastiano Mercadante, Claudio Adile, Arturo Cuomo, Federica Aielli, Andrea Cortegiani, Alessandra Casuccio & Giampiero Porzio. (2015) Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study. Journal of Pain and Symptom Management 50:5, pages 579-586.
Crossref
Crossref
Sebastiano Mercadante. (2015) Breakthrough pain in cancer patients. Current Opinion in Anaesthesiology 28:5, pages 559-564.
Crossref
Crossref
Sebastiano Mercadante, Marzia Lazzari, Carlo Reale, Arturo Cuomo, Flavio Fusco, Paolo Marchetti, Rocco D. Mediati, Bruno Chiurazzi, Libero Ciuffedra, Augusto Caraceni, Vincenzo Iaffaioli, Massimo Luzzani, Giuseppe Micheletto, Alfonso Papa, William Raffaeli, Alessandro Valle, Michele Caruso, Francesco Di Costanzo, Gianpaolo Pinato, Filippo Nardi, Sandro Barni, Silvia Natoli, Massimo Mammucari, Alessandro F. Sabato & Mario Dauri. (2015) Italian Oncological Pain Survey (IOPS). The Clinical Journal of Pain 31:3, pages 214-221.
Crossref
Crossref
Richard J. Bodnar. (2014) Endogenous opiates and behavior: 2013. Peptides 62, pages 67-136.
Crossref
Crossref
Sebastiano Mercadante, Giovanna Prestia, Claudio Adile & Alessandra Casuccio. (2014) Intranasal Fentanyl Versus Fentanyl Pectin Nasal Spray for the Management of Breakthrough Cancer Pain in Doses Proportional to Basal Opioid Regimen. The Journal of Pain 15:6, pages 602-607.
Crossref
Crossref